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Public Health, USA
Marc A. Nascarella  Gradient, USA
 Nanoparticles are particles with lengths that range from 1 to 100 nm. They are increas-
ingly being manufactured and used for commercial purpose because of their novel and
unique physicochemical properties. Although nanotechnology-based products are gener-
ally thought to be at a pre-competitive stage, an increasing number of products and mate-
rials are becoming commercially available. Human exposure to nanoparticles is therefore
inevitable as they become more widely used and, as a result, nanotoxicology research is
now gaining attention. However, there are many uncertainties as to whether the unique
properties of nanoparticles also pose occupational health risks. These uncertainties arise
because of gaps in knowledge about the factors that are essential for predicting health
risks such as routes of exposure, distribution, accumulation, excretion and dose-response
relationship of the nanoparticles. In particular, uncertainty remains with regard to the
nature of the dose-response curve at low level exposures below the toxic threshold. In fact,
in the literature, some studies that investigated the biological effects of nanoparticles,
observed a hormetic dose-response. However, currently available data regarding this topic
are extremely limited and fragmentary. It therefore seems clear that future studies need
to focus on this issue by studying the potential adverse health effects caused by low-level
exposures to nanoparticles.
Key words: nanoparticles, hormesis, health effects.
INTRODUCTION
Nanotechnology is an emerging multidisciplinary science that
involves applications based upon the synthesis of molecules in the
nanoscale (10–9 m) size range. This technology has the ability to manipu-
late matter on a near-atomic scale to produce new structures, materials
and devices with unique physical and chemical properties (NIOSH 2009).
These characteristics enhance versatility and efficacy in product develop-
ment, resulting in more effective industrial and medical applications,
concomitant with the production of more versatile and efficacious prod-
ucts (Colvin 2003). Consequently, nanotechnology has the potential to
dramatically improve the effectiveness of a number of existing consumer
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and industrial products and could have a substantial impact on the devel-
opment of new products in all sectors, ranging from disease diagnosis and
treatment to environmental remediation (NIOSH 2009). In fact, research
in nanoscale technologies is growing rapidly worldwide and the National
Science Foundation (NSF 2001) estimates that, by 2015, nanotechnology
will have a $1 trillion impact on the global economy and will employ 2
million workers, 1 million of whom may be in the United States while Lux
Research (2007) predicts that new emerging nanotechnology applica-
tions will affect nearly every type of manufactured product through the
middle of the next decade, becoming incorporated into 15 % of global
manufacturing output and totalling $2.6 trillion in 2014.
According to ISO/TS 27687 (ISO 2008), a nano-object is defined as
material with one, two, or three external dimensions in the size range
from approximately 1–100 nm. Subcategories of nano-objects are
nanoplate, a nano-object with one external dimension at the nanoscale,
nanofiber, a nano-object with two external dimensions at the nanoscale
with a nanotube defined as a hollow nanofiber and a nanorod as a solid
nanofiber and nanoparticle, a nano-object with all three external dimen-
sions at the nanoscale. Nano-objects are commonly incorporated in a
larger matrix or substrate referred to as a nanomaterial.
Reducing particle size increases surface area and modifies unique
physicochemical properties such as high conductivity, strength, durabili-
ty, and chemical reactivity (Nel et al. 2006). For these reasons, the indus-
trial applications of nanomaterials are very wide-ranging and include
those that may lead to more efficient water purification, stronger and
lighter building materials, increased computing power and speed,
improved generation and conservation of energy and new tools for the
diagnosis and treatment of diseases (Card et al. 2008). The latest update
of the nanotechnology consumer product inventory, maintained by the
Project on Emerging Nanotechnologies (PEN), includes over 1,000 prod-
ucts, and has grown nearly 4-fold since it was established in March 2006
(PEN 2009). However, the PEN database does not evaluate whether a
product truly contains nanoparticles, it simply reports manufacturer
claims, hence the number of nanoenabled products is probably lower.
Nonetheless, new nanotechnology consumer products are coming on the
market at the rate of three to four per week (PEN 2008). In fact, silica
(SiO2) nanoparticles are used as biomarkers for leukaemia cell identifi-
cation (Santra et al. 2001), cancer therapy (Hirsch et al. 2003), drug deliv-
ery (Venkatesan et al. 2005) and they also find extensive applications in
chemical mechanical polishing and as additives to drugs, cosmetics, print-
er toners, varnishes and food (Lin et al. 2006). Metal nanoparticles such
as cerium oxide nanoparticles have wide-ranging applications for solar
and fuel cells, gas sensors, abrasives for chemical mechanical planariza-
tions, oxygen pumps, metallurgic, glass and ceramic applications (Zheng
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et al. 2005; Gao et al. 2006); titanium dioxide, in nanoparticle form, is one
of the most important materials for photocatalysts, paints, sterilization,
bio-medical ceramic and implanted biomaterials, cosmetics and pharma-
ceuticals (Gelis et al. 2003; Sun et al. 2004); silver nanoparticles are used
in bedding, washers, water purification, toothpaste, shampoo and rinse,
infant nipples and nursing bottles, fabrics, deodorants, filters, kitchen
utensils, toys and humidifiers (Maynard 2006). Finally, carbon nanotubes
(CNTs) are currently of interest for a variety of applications in electron-
ics, reinforced rods, micro-fabricating conjugated polymer activators,
biosensors and enhanced electron/scanning microscopy imaging tech-
niques (Shvedova et al. 2009).
The increase in nanoparticle applications has led to an increase in
concern about their potential human toxicity and their environmental
impact. Indeed, as a result of their small size and unique physicochemi-
cal properties, the toxicological profiles of nanoparticles may differ con-
siderably from those of larger particles composed of the same materials
(Borm et al. 2006; Nel et al. 2006). Consequently, in the last few years, nan-
otoxicology has emerged in order to clarify the relationship between the
physical and chemical properties (eg. size, shape, surface chemistry, com-
position, aggregation and surface area) of nanomaterials and the induc-
tion of toxic biological responses (Lynch et al. 2006). In the literature,
most of the studies, that have addressed this topic have focused their
attention on the adverse effects of nanoparticles on the respiratory sys-
tem (Mitchell et al. 2007; Park et al. 2008, 2009; Wang et al. 2008; Sung et
al. 2009). However, when inhaled nanoparticles are deposited in lung
cells and translocated through epithelial and endothelial cells into the
blood and lymph circulation, they may reach potentially sensitive target
sites including bone marrow, lymph nodes, spleen, heart and central
nervous system. Several studies have also investigated the toxic effects of
nanoparticles on other organs and systems (Lai et al. 2008; Belyanskaya et
al. 2009; Legramante et al. 2009; Murray et al. 2009; Sharma et al. 2009;
Simeonova and Erdely 2009). Nevertheless, there is a general lack of
information concerning the effects of manufactured nanomaterials on
human health and the environment and, in particular, uncertainty
remains with regard to the nature of the dose-response curve for low level
exposures. Furthermore, since these studies investigated the toxic effects
of different nanoparticles of the same compound, the results reported for
a particular type of nanomaterial cannot be considered representative of
the whole class. In fact, nanoparticles of the same compound can have
different toxicological profiles because of differences in the chemical
composition, in the aggregation and surface area, in the shape or size. All
of these factors can affect the dose-response relationship.
Hormesis is a dose-response relationship characterized by a low-dose
stimulation and a high-dose inhibition (Eaton and Klaassen 2001). The
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hormetic dose response has been typically represented in graphs as an
inverted U- or J-shaped dose response, depending on the endpoint meas-
ured. For example, in the cases of growth, cell proliferation, memory and
longevity, hormetic responses have typically been graphed as an inverted
U-shaped dose response. In the case of endpoints such as disease inci-
dence (e.g., tumour formation, cardiovascular disease, genotoxicity, birth
defects), hormetic effects are typically graphed as a J-shaped dose
response. However, this broad range of inverted U- and J-shaped dose
response relationships are all considered examples of hormesis
(Calabrese 2009).
In this review we have explored the possible presence of hormesis in
the studies that have investigated the adverse health effects of nanoparti-
cles.
IN VITRO STUDIES
In the literature there are some in vitro toxicological studies (Table 1)
that reported a hormetic dose-response following exposure to nanoparti-
cles, in particular carbon nanotubes, quantum dots, metal nanoparticles.
The molecular mechanisms underlying the pathological behaviour of
carbon nanotubes (CNTs) were investigated and observed in several in
vivo and in vitro studies. The results obtained by Pulskamp et al. (2007a)
are particularly interesting in relation to the purpose of our review. In this
study, human alveolar epithelial cells A549 were exposed at various con-
centrations (5-100 µg/ml) of different CNT preparations (NT1-AP, the
most impure form; NT2-AT, free of carbonaceous materials and marked-
ly reduced in metal content; NT2-DMF, free of carbonaceous materials
but still with high levels of metals) to elicit oxidative stress response. The
NT1-AP were commercially purchased (Nanostructured and Amorphous
Materials Inc.) and were synthesized using chemical vapour deposition.
The NT2-DMF were obtained from NT2 (synthesized by means of the
laser vaporization method using graphite targets doped with equal parts
of Ni and Co) after purification and separation from the amorphous car-
bon-containing preparations using DMF (N, N-dimethyl formamide).
Finally, NT2-AT were obtained from NT2-DMF after acid treatment with
HNO3 to yield a purified version with reduced catalyst concentrations.
Before use in the experiment, the CNTs were precipitated in acetone and
resuspended in bidistilled water, sedimented again by centrifugation, and
finally added to growth media and diluted to the final concentrations.
Prior to use, the samples were sonicated and vigorously mixed to break
up the nanotube bundles and sediments. To keep the sample prepara-
tions free from other disturbing chemical additives like DMSO or SDS
(which facilitate CNT dispersion), a certain degree of CNT aggregation
was accepted in the sample fluid. In order to determine oxidative stress,
cultured cells were assayed for short-term incubation of 10 minutes as
I. Iavicoli and others
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well as for an extended period of 24 hours. Data provided by this work
showed that the NT2-AT did not elicit reactive oxygen species (ROS),
while NT2-DMF caused a significant increase in ROS production after
only 24 hours and finally the most impure form of CNTs induced an
increase in ROS after 10 minutes and 24 hours. Moreover, NT1-AP
showed a stimulation of ROS production at 5 and 10 µg/ml, while the
ROS levels decreased at 50 and 100 µg/ml.
The same author (Pulskamp et al. 2007b) studied, in the rat alveolar
macrophage cell line NR8383, the cytotoxic effects caused by exposure to
different types of commercially available CNTs. Viability of the cells treat-
ed with 5, 10, 50 and 100 µg/ml of nanoparticles was evaluated using the
3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl -2H- tetrazolium bromide
(MTT) test and the 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disul-
fophenyl)-2H-tetrazolium (WST-1) assay. Results of the MTT test showed
a dose-dependent decrease in cell viability but, surprisingly, data of the
WST-1 test did not agree with the MTT test and they did not indicate a
loss of viability due to exposure to all kinds of CNTs. Furthermore, at
lower concentrations, in the WST-1 assay, an increase in viability was
observed, which rather suggested an increase in proliferation upon par-
ticle stimulation. These findings revealed a low-dose stimulation and a
high-dose inhibition that could be explained by the presence of the
hormetic phenomenon.
Jan et al. (2008) explored the possibility of building a high-content,
high-throughput cytotoxicity assay platform based on high-content
screening technology to meet the demands for nanotoxicity studies. In
this attempt they carried out several experiments using differentiated and
undifferentiated NG108-15 murine neuroblastoma cells and HepG2
human hepatocyte carcinoma cells exposed to cadmium telluride quan-
tum dots (CdTe QDs) and to gold nanoparticles, respectively. In particu-
lar, NG108-15 murine neuroblastoma cells were exposed to thioglycolic
acid (TGA)-capped CdTe QDs (TGA-QD) and to a TGA-capped CdTe QD
produced in the presence of gelatin (Gelatin-QD). Both of these QDs had
a diameter of 3 nm. To investigate the different toxicological effects of
TGA-QD and of Gelatin-QD, a neurite outgrowth assay was used. The
results showed that a 6-hour treatment with 25 nM of TGA-QDs prior to
neuronal differentiation reduced the total neurite length by approxi-
mately 50 %. However, treatment with 25 nM of Gelatin QDs led to a
slight increase in total neurite length. This difference was most evident at
the 50 nM dose of exposure, where all TGA-QD treated cells were killed
while Gelatin-QD treated cells still exhibited some viability and a moder-
ate level of neurite outgrowth. The authors suggested that this contradic-
tory effect at low dose could be a hormetic response, as hormesis is fre-
quently observed as a result of low-dose stimulation in toxicological stud-
ies. In fact, the mechanisms involved in countering the cytotoxic effect of
Exposure to Nanoparticles and Hormesis
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a short, non lethal low-dose treatment might have stimulated the forma-
tion of neurites.
Stern et al. (2008) studied the toxic effects of another type of QDs,
with a core material of indium gallium phosphide (InGaP-QDs), on
porcine renal proximal tubule cell line (LLC-PK1) treated for 24 and 48
h with concentrations of InGaP-QDs in the range of 4 – 1000 nM.
Cytotoxicity of this nanomaterial was determined by the MTT assay and,
in the 24h experiment, the results showed an important loss of cell via-
bility at concentrations exceeding 100 nM. Surprisingly, exposure of LLC-
PK1 to doses of InGaP-QDs in the range of 30 – 80 nM caused a signifi-
cant increase in cell viability. Therefore, these results showed the pres-
ence of a hormetic dose-response.
In 2005, Braydich-Stolle et al. (2005) assessed the toxicity of metal
nanoparticles in the male germ line. The authors exposed the spermato-
gonial stem cell line C18-4 to silver (Ag-NPs, 15 nm in diameter), molyb-
denum (Mo-NPs, 30 nm in diameter) and aluminium nanoparticles (30
nm in diameter), dispersed in phosphate buffered saline, at concentra-
tions in the range of 5 – 100 µg/ml. The evaluation of the germline stem
cell mitochondrial function and viability, after treatment with Mo-NPs,
showed the presence of a hormetic-like biphasic dose response. In fact,
the results of this study indicated that, in the C18-4 cell line, Mo-NPs exert
toxic effects on cellular metabolic activity at concentrations of 50 µg/ml
and above whereas, at low doses (5 – 25 µg/ml), they stimulate the mito-
chondrial function.
Another example of hormesis was observed in a subsequent study that
investigated the potential cytotoxicity, the effects on the production of
cytokines by and on the proliferation of peripheral blood mononuclear
cells (PBMCs) exposed for 72 h to 1, 3, 5, 10, 20 and 30 ppm of Ag-NPs
(Shin et al. 2007). The cytotoxic effects of these nanoparticles were eval-
uated using an aqueous cell proliferation assay and a 5-chloromethylfluo-
rescein diacetate (CMFDA) assay. Results showed a dose-response rela-
tionship characterized by a low-dose stimulation and a high-dose inhibi-
tion. In fact, cell proliferation was found to be significantly decreased at
Ag-NPs concentrations exceeding 15 ppm whereas, at lower doses an
important stimulatory effect was observed.
Spherical silver nanoparticles of 7 – 20 nm in diameter were also used,
as colloidal aqueous suspension, by Arora et al. (2008) to study the cellu-
lar responses of the cell lines A431 (human skin carcinoma) and HT-1080
(human fibrosarcoma) exposed to different concentrations of Ag-NPs.
Particularly interesting was the effect of these nanoparticles on caspase-3
activity. In fact, in A431 cells, Ag-NPs induce caspase-3 production at con-
centrations in the range of 1.56 – 6.25 µg/ml but, at concentrations ≤
0.78 and ≥ 12.5 µg/ml, data showed a lack of caspase-3 activity. Similar
results were obtained in HT-1080 cells where Ag-NPs induce caspase-3
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production at concentrations in the range of 0.78 – 6.25 µg/ml whereas,
at concentrations ≤ 0.39 and ≥ 12.5 µg/ml caspase-3 activity was not
detected. Therefore, these findings could be explained by the presence
of a hormetic response.
Similar results were obtained by investigating the toxic effects of low
exposure levels of Ag-NPs (7 – 10 nm in diameter), stabilized with poly-
ethylenimine, in human hepatoma derived cell line HepG2 (Kawata et al.
2009). To evaluate the cytotoxicity of Ag-NPs, cells were exposed for 24
hours to 0.1, 0.2, 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 mg/l of the nanoparticles.
At high exposure levels, the tested material exhibited a marked cytotoxi-
city. In fact, the cell viability of the HepG2 cells drastically decreased for
Ag-NP concentrations > 1 mg/l. Surprisingly, non-cytotoxic doses (0.1 –
0.5 mg/l) of the nanoparticles significantly increased the viability of
HepG2 cells. Hence, the low-dose stimulation and the high-dose inhibi-
tion of cell viability showed by the results of this study was interpreted by
the authors as being due to hormesis.
A study carried out in human bronchial epithelial BEAS 2B cells to
evaluate the cytotoxicity and genotoxicity of graphite nanofibers
obtained similar results (Lindberg et al. 2009). The nanomaterials were
dispersed in bronchial epithelial growth medium cell culture and sub-
jected to ultrasonication for 20 min prior to addition to the cell cultures.
The viability of cells, exposed for 24, 48 and 72 h to eight doses (1, 5, 10,
20, 40, 60, 80 and 100 µg/cm2) of nanofibers was determined using the
Trypan blue dye exclusion technique by counting the number of living
cells under phase-contrast microscopy. In general, the number of viable
cells decreased with the incubation time, dropping to 50 % of the respec-
tive control value at about 10 – 40 µg/cm2 in the 24-h treatment and 40 –
60 µg/cm2 in the 48-h and 72-h treatment. However, interestingly, in the
24-h treatment a significant increase in the number of living cells was
observed at the lowest dose (1 µg/cm2). However, in the evaluation of via-
bility of cell cultures exposed to CNTs or to carbon nanofibers, it is
important to note that these nanoparticles may show unexpected behav-
iour, such as aggregation or interference with optical measurements,
when routine in vitro assays are performed (Pfaller et al. 2010). These
interferences represent an important confounding factor because they
can be misinterpreted as cell death.
Finally, in a study performed to assess the efficacy of paclitaxel-loaded
in sterically stabilized, biocompatible and biodegradable sterically stabi-
lized mixed phospholipid nanomicelles (P-SSMM) and of paclitaxel dis-
solved in dimethyl sulfoxide (P-DMSO) in circumventing the P-glycopro-
tein-mediated paclitaxel resistance in the human breast cancer cell line
BC19/3 revealed also the presence of a biphasic dose – response (Önyük-
sel et al. 2009). In fact, exposure of BC19/3 to P-SSMM and to P-DMSO
at concentrations in the range of 0.128 – 2000 ng/ml showed a slight
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increase in cell survival at the lower doses and a significant inhibition of
viability at concentrations exceeding 15 ng/ml.
IN VIVO STUDIES
A hormetic-like response has been also observed in diverse in vivo
studies (Table 2). In 2007, Roberts et al. (2007), while determining the
behaviour of a water-soluble, lysophophatidylcholine-coated single-walled
carbon nanotube (LPC-SWCNTs) in the presence of Daphnia magna, an
aquatic invertebrate, observed a typical biphasic dose-response. The
assessment of survival of Daphnia magna, exposed to 0.1, 0.25, 0.5, 1 and
2.5 mg/L of LPC-SWCNTs showed that the peak survival was reached at
an LPC-SWCNT concentration of 0.5 mg/L. At higher test concentra-
tions, survival decreased in a dose-dependent manner as opposed to sur-
vival at concentrations below 0.5 mg/L in which survival increased in a
dose-dependent manner. On the basis of these findings, the authors sug-
gested the presence of a hormetic response in which the organism gains
some benefit from low-level exposure, until a threshold concentration is
reached and toxicity occurs.
To evaluate the toxicity of nanosized titanium dioxide (TiO2),
Drobne et al. (2009) performed a laboratory single-species toxicity test
with the terrestrial arthropod (Porcellio scaber, Isopoda, Crustacea). The
isopods were exposed for 14 days to 10, 100 and 1000 µg/g dry food of
two different TiO2 nanoparticles (< 25 nm in diameter and < 75 nm in
diameter). The results of this study showed that there was a threshold-like
dose-dependent pattern for feeding parameters when animals were fed
on small nanosized TiO2, while when animals were exposed to larger
nano-TiO2 , no recognizable dose–response relationship pattern was
observed for feeding parameters. On the basis of previous work (Drobne
and Hopkin 1995), a reduction in feeding rate was expected as recorded
many times upon exposure to metal-dosed food but, contrary to expecta-
tions, nanosized TiO2 enhanced feeding rate. The authors suggested that
the increase in feeding parameters could be a hormetic-like response
which can have complex time response dynamics.
TiO2 nanoparticles of different sizes (10 and 30) were also used to
assess ecotoxicity to the freshwater green alga Pseudokirchneriella subcapita-
ta (Hartmann et al. 2010). In particular, the authors assessed the growth
rate inhibition of algae by exposing them for 72 h to 16 concentrations
(0.6 – 250 mg/L) of several TiO2 nanoparticles. Nanoparticles stock solu-
tions were prepared by suspending the TiO2 nanoparticles in algal test
medium in a concentration of 250 mg/L followed by 10 min sonication
in a water bath. These suspensions were sonicated again 10 min prior to
preparation of test suspensions. The results of this study showed a ten-
dency of the smallest (10 nm) nanoparticles to induce higher inhibition
at lower concentrations. However, an extra data analysis, carried out
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using a three parameter log logistic curve fitting with a hormesis param-
eter added as described by Brain and Cousens (1989) and with a lack of
fit model as described by Cedergreen et al. (2005), revealed, for the larg-
er nanoparticles (30 nm), a biphasic relationship with a statistically sig-
nificant stimulation of the algal growth rate at lower concentrations and
an inhibition at higher doses.
Recently, a study by Mortimer et al. (2010), conducted on the ciliated
protozoa Tetrahymena thermophila exposed to 31.25, 62.5, 125, 250 and 500
mg/L of copper nanoparticles (Cu-NPs) and to 1.85, 5.55, 8.33, 12,5 and
25 of zinc nanoparticles (Zn-NPs) showed the presence of a hormetic
response. The toxic effects of these nanoparticles to protozoa were eval-
uated at two exposure times (4 and 24 h), using propidium iodide stain-
ing and cellular ATP concentration that are both correlated to the cell
viability. Interestingly, at the lowest and sub-toxic concentrations tested
(31.25 mg/L and 1.85 mg/L for Cu-NPs and Zn-NPs, respectively), the
nanoparticles had a stimulatory effect on ATP concentration of
Tetrahymena thermophila. The hormetic phenomenon was detected only by
the ATP measurements and not in the propidium iodide staining assay.
The assessment of the phytotoxicity of Zn-NPs (35 nm in diameter)
and zinc oxide nanoparticles (ZnO-NPs, 20 ± 5 nm in diameter) on seed
germination and root growth of radish, rape and ryegrass showed a
hormetic dose-response (Lin and Xing 2007). No significant root growth
inhibition was observed under low concentrations (less than 10 mg/L for
rape and ryegrass and 20 mg/L for radish). In particular, the exposure of
radish and rape to lower doses of ZnO-NPs and the exposure of ryegrass
to lower doses of Zn-NPs caused a slight increase in root length whereas,
root growth of these plant species was clearly restricted with increasing
concentration and was almost terminated at 200 mg/L.
Recently, a similar study, carried out by Ma et al. (2010), showed the
ability of other types of nanoparticles to induce a biphasic dose-response
relationship. As in the previous study, the phytotoxicity of cerium (CeO2-
NPs), lanthanum (La2O3-NPs), gadolinium (Gd2O3-NPs) and ytterbium
(Yb2O3-NPs) oxide nanoparticles was evaluated in several higher plant
species by means of root elongation experiments. The effects of exposure
to different concentrations (0.2 – 2000 mg/L) of rare earth oxide NPs on
root elongation of rape were particularly interesting. In fact, after expo-
sure to La2O3-NPs and Yb2O3-NPs, root elongation in this plant was
enhanced at less than 0.8 mg/L but, as the concentration increased, root
growth was restricted and almost halted at 200 and 2000 mg/L.
Therefore, La2O3-NPs and Yb2O3-NPs had positive effects on root elonga-
tion at low concentrations (< 0.8 mg/L), but negative effects at higher
concentrations. The authors suggested that these findings could be
explained by “hormesis effects”.
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DISCUSSION AND CONCLUSION
The hormetic dose-response may be reliably described by a stimula-
tion in the low dose zone and an inhibitory response at higher doses
(Calabrese 2009) The last three decades have witnessed growing interdis-
ciplinary evidence of hormetic - biphasic dose-responses that are charac-
terized by remarkably similar quantitative features of the dose-response
and similar underlying mechanistic explanatory strategies. It is the emer-
gence and integration of these findings from diverse biomedical fields
that has led to consolidation of the hormesis dose- response concept
(Calabrese 2008a).
According to Stebbing’s theory, the key factor in the hormesis con-
cept is not the chemical but, rather, the organism. In fact, the examples
gathered from the literature reviewed by Stebbing led him to suggest that
hormesis is not a specific effect of the agent that induces it, since it can
be induced by such a wide variety of agents of different kinds.
Furthermore, the ubiquity of hormesis that follows a similar pattern (beta
curve) in many taxa, suggests a common explanation. Therefore the
hypothesis tested was that hormesis is a consequence of an adaptive
response common to biological systems to the inhibitory effect that dif-
ferent agents have in common at higher concentrations (Stebbing, 1998).
In other words, the hormetic response is found in the organism’s over-
compensation to a disruption in homeostasis (Stebbing 1987, 1998). If
this is the case, then any agent - even in nanoparticle form - that can dis-
rupt homeostasis (i.e. cause toxicity) would be expected to induce a
hormetic response to the damage induced. The Stebbing theory does not
infer that all chemicals will be hormetic for all endpoints. It does, howev-
er, imply that biological systems respond in a hormetic manner to signals
that indicate stress, toxicity or disruptions in homeostasis (Calabrese
2008b).
In fact, the occurrence of hormetic dose-response in the toxicological
literature is extremely high and, to date, approximately 8000 dose-
responses have been reported in the hormesis database (Calabrese and
Blain 2005). Nevertheless, to our knowledge, this review represents the
first attempt to summarize current data regarding the possible induction
of hormesis by nanoparticles.
In recent years, the number of studies that have investigated the
adverse health effects of nanoparticles has increased significantly because
the massive development of nanotechnologies has led to considerable
concern regarding the potential biological effects and human toxicity of
these materials. However, the toxicity of nanoparticles has not been fully
evaluated and, at present, there are many uncertainties as to whether the
unique properties of engineered nanoparticles also pose a health risk for
humans. These uncertainties arise because of gaps in knowledge about
the factors that are essential for predicting health risks such as the nature
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of the dose-response curve at low level exposures below the toxic thresh-
old. In fact, most of the in vitro and in vivo studies that investigated and
identified several toxicological effects of CNTs, metal nanoparticles or
other nanomaterials used high doses of these chemicals, at exposure lev-
els in excess of those encountered in the different environmental matri-
ces or workplaces. Obviously, this feature represents a serious problem
when trying to detect the presence of a hormetic response. Toxicological
assessments that include either too few doses, too high doses or inade-
quate dose spacing are not capable of accurately assessing the nature of
the dose-response relationship. Consequently, using only high doses of
exposure, these studies might underestimate the occurrence of hormetic
responses.
Although, the Stebbing theory suggests that all chemicals have the
capacity to induce a hormetic response in some experimental settings, a
clear structural specificity exists in the induction of hormetic-like bipha-
sic dose responses for specific endpoints and experimental conditions
(Calabrese 2008b). If this is true, then the contribution of the chemical
structure and composition of nanoparticles to the induction of hormesis
must be addressed very carefully since these materials are manipulated
on a near-atomic scale and their toxicological profiles may be quite dif-
ferent from those of larger particles with the same chemical composition
(NIOSH 2009). Furthermore, the toxicity of nanoparticles is not only
related to their chemical composition but there are several other param-
eters that must be taken into account. In fact, current evidence suggests
that the biological impact and the biokinetics of nanoparticles are
dependent on their small size (surface area and size distribution), chem-
ical composition (purity, crystallinity, electronic properties, etc.), surface
structure (surface reactivity, surface groups, inorganic or organic coat-
ings, etc.), solubility, shape, and aggregation (Nel et al. 2006). Hence, a
correct evaluation of the induction of a hormetic response by nanoparti-
cles is not possible without a preliminary, accurate and precise character-
ization of these materials.
The hormetic dose-response must also be seen within a temporal con-
text, that is, as a dose - time - response relationship. The reason for incor-
porating a temporal feature in hormesis is that it may also be described
as a modest overcompensation response following an initial disruption in
homeostasis, i.e. a type of rebound effect. The hormetic dose response
therefore represents the effects of a repair process that slightly or mod-
estly overshoots the original homeostatic set point, resulting in the low-
dose stimulatory response (Calabrese 1999, 2001). The assessment of the
dose response is therefore a dynamic process. Whereas harmful agents
may induce toxicity in affected biological systems, the organism or bio-
logical system is not a passive entity but will respond to damage signals
with a coordinated series of temporally- mediated repair processes. This
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dynamic aspect of toxicological assessment requires the inclusion of not
only a broad range of doses but also a series of temporal evaluations (i.e.
repeated measurements). Only by assessing the dose-response process
over time can an accurate assessment of the dose-response relationship
be determined, within which the hormetic dose response is best revealed
(Calabrese 2008b). Unfortunately, also in the studies that we have report-
ed in this review the presence of a hormetic response was not evaluated
over time, therefore it would be of great interest to repeat these experi-
ments using a series of temporal evaluations to better define the occur-
rence of hormesis.
In conclusion, the results of some studies that have investigated the
toxicological effects of the nanoparticles suggest that these chemicals
may be able to induce, in some experimental settings, a hormetic
response for specific endpoints. Nevertheless, the data currently available
on this topic are extremely limited and fragmentary and for this reason,
at the present time, it is not possible to reach comprehensive conclusions
or a broad consensus. Consequently, more research is needed on the
occurrence of the hormetic dose-response elicited by exposure to
nanoparticles. However, to be able to detect the real presence of horme-
sis, future studies should focus on deep and accurate characterization of
nanoparticles, they should use a broad range of exposure doses and also
include a series of temporal evaluations.
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